Skip to main content
. Author manuscript; available in PMC: 2023 Jul 1.
Published in final edited form as: Nutr Metab Cardiovasc Dis. 2022 Apr 11;32(7):1681–1692. doi: 10.1016/j.numecd.2022.04.002

Table 1.

Baseline characteristics of GenSalt and BHS participants.

GenSalt Study BHS (N=1,249)

Salt-Sensitive (N=50) Salt-Resistant (N=50)

Age, years, mean (SD) 51.8 (6.45) 42.2 (10.6) 48.2 (5.28)
Male, n (%) 23 (46%) 26 (52%) 515 (41%)
Race, n (%)
 Asian 50 (100%) 50 (100%) 0 (0%)
 White 0 (0%) 0 (0 %) 822 (66%)
 Black 0 (0%) 0 (0%) 427 (34%)
Current Drinking, n (%) 15 (30%) 6 (12%) 696 (56%)
Physical Activity, MET-hours per day, mean (SD) 20.6 (12.0) 18.4 (11.7) 12.0 (10.9)
Obesity, n (%) 8 (16%) 9 (18%) 644 (52%)
Hypertension, n (%) 45 (90%) 11 (22%) 775 (62%)
Anti-hypertension medication, n (%) 0 (0%) 0 (0%) 433 (35%)

BHS: Bogalusa Heart Study; SD: standard deviation; MET: metabolic equivalent